Abstract
Tumour-necrosis factor-α (TNF-α) is a cytokine that contributes to a variety of inflammatory disease states1. The protein exists as a membrane-bound precursor2,3 of relative molecular mass 26K which can be processed by a TNF-α-converting enzyme (TACE), to generate secreted 17K mature TNF-α. We have purified TACE and cloned its complementary DNA. TACE is a membrane-bound disintegrin metalloproteinase. Structural comparisons with other disintegrin-containing enzymes indicate that TACE is unique, with noteable sequence identity to MADM4, an enzyme implicated in myelin degradation, and to KUZ5, a Drosophila homologue of MADM important for neuronal development. The expression of recombinant TACE (rTACE) results in the production of functional enzyme that correctly processes precursor TNF-α to the mature form. The rTACE provides a readily available source of enzyme to help in the search for new anti-inflammatory agents that target the final processing stage of TNF-α production.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
204,58 €
only 4,01 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Vassalli, P. The pathophysiology of tumour necrosis factors. Annu. Rev. Immunol. 10, 411–452 (1992).
Decker, T., Lohmann-Matthes, M. L. & Gifford, G. E. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. mmuno. 138, 957–962 (1987).
Kriegler, M., Perez, C., DeFay, K., Albert, I. & Lu, S. D. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53, 45–53 (1996).
Howard, L., Lu, X., Mitchell, S., Griffiths, S. & Glynn, P. Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. Biochem. J. 317, 45–50 (1996).
Rooke, J., Pan, D., Xu, T. & Rubin, G. M. KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Science 273, 1227–1231 (1996).
Mohler, K. M. et al. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370, 218–220 (1994).
Gearing, A. et al. Processing of tumor necrosis factor-α precursor by metalloproteases. Nature 370, 558–561 (1994).
Wolfsberg, T. G. & White, J. M. ADAMs in fertilization and development. Dev. Biol. 180, 389–401 (1996).
Gomis-Reuth, F. X. et al. Refined 2.0 angstrom x-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin. J. Mol. Biol. 239, 513–544 (1994).
Van Wart, H. E. & Birkedal-Hansen, B. The cysteine switch: a principle of regulation of metalloprotease activity with potential applicability to the entire matrix metalloprotease gene family. Proc. Natl Acad. Sci. USA 87, 5578–5581 (1990).
Grams, F., Huber, R., Kress, L. F., Moroder, L. & Bode, W. Activation of snake venom metalloproteases by a cysteine switch-like mechanism. FEBS Lett. 335, 76–80 (1993).
Shannon, J. D., Baramova, E. N., Bjarnason, J. B. & Fox, J. W. Amino acid sequence of a Crotalus atrox venom metalloprotease which cleaves type IV collagen and gelatin. J. Biol. Chem. 264, 11575–11583 (1989).
Zhou, Q., Dangelmaier, C. & Smith, J. B. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregatin by binding to collagen via its disintegrin-like domain. Biochem. Biophys. Res. Commun. 219, 720–726 (1996).
Gould, R. J. et al. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exp. Biol. Med. 195, 168–171 (1990).
Weskamp, G., Kratzschmar, J., Reid, M. S. & Blobel, C. P. MDC0, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J. Cell Biol. 132, 717–726 (1996).
Suffys, P., Beyaert, R., Van Roy, F. & Fiers, W. Involvement of a serine protease in tumor necrosis factor-mediated cytotoxicity. Eur. J. Biochem. 178, 257–265 (1988).
Bennett, T. A., Lynam, E. B., Sklar, L. A. & Rogelj, S. Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes. Functional consequences for neutrophil aggregation. J. Immunol. 156, 3093–3097 (1996).
Mullberg, J. et al. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and te p60 TNF receptor. J. Immunol. 155, 5198–5205 (1995).
Arribas, J. et al. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271, 11376–11382 (1996).
Crowe, P. D. et al. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181, 1205–1208 (1995).
Moyer, M., Rose, D. & Burkhart, W. Elutin of proteins from polyacrylamide gels onto the HP sequencing column. in Techniques in Protein Chemistry (ed. Crabb, J.) 195–204 (Academic, San Diego, 1994).
Granados, R. R., Guoxun, L., Derksen, A. C. G. & McKenna, K. A. A new cell line from Trichoplusia ni (BTI-Tn-5BI-4) susceptible to Trichoplusia single enveloped nuclear polyhedrosis virus. J. Invert. Path. 64, 260–266 (1994).
Ziegler-Heitbrook, et al. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cander 41, 456–461 (1988).
Morris, S. A. et al. Inhibition of organ invasion by the matrix metalloprotease inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res. 55, 3629–3633 (1995).
O'Byren, E. M. et al. Oral administration of a matrix metalloprotease inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits. Inflam. Res. 44 (suppl. 2), S117–S118 (1995).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Moss, M., Jin, SL., Milla, M. et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385, 733–736 (1997). https://doi.org/10.1038/385733a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/385733a0
Further reading
-
Congenital iRHOM2 deficiency causes ADAM17 dysfunction and environmentally directed immunodysregulatory disease
Nature Immunology (2022)
-
Soluble tumor necrosis factor-alpha-induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma
Journal of Neuroinflammation (2021)
-
Lentiviral CRISPR-guided RNA library screening identified Adam17 as an upstream negative regulator of Procr in mammary epithelium
BMC Biotechnology (2021)
-
Inflammatory activation of surface molecule shedding by upregulation of the pseudoprotease iRhom2 in colon epithelial cells
Scientific Reports (2021)
-
Sitafloxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide-stimulated THP-1 cells
Scientific Reports (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
